Skip to content
  • Facebook
  • Twitter
This translation is automatically provided by Google; please refer to the original English version for appropriate wording.
Take on Typhoid

Take on Typhoid

  • Home
  • Why Typhoid?
    • Typhoid & Related Salmonelloses
    • Global Research
    • Links & Resources
  • The Issues
    • Vaccines
    • WASH
    • Drug-Resistant Typhoid
    • Treatment
    • Diagnostics
    • Related Issues
  • Resources & Tools
    • Talk About Typhoid
    • Global Policy
    • Country Tools
    • Infographics
    • Fact Sheets
    • TCV Cost-effectiveness
    • Share on Social
  • Blog & News
    • Blog
    • News
    • Publications
    • Newsletter
  • International Conference
    • 13th International Conference
    • Call for Late-Breaker Abstracts
    • Past Conferences
    • Conference Travel
    • Travel Awards
  • About Us
    • About the Coalition against Typhoid
    • About the Typhoid Vaccine Acceleration Consortium

Senegal Resources

Fact sheet [English] [Français]
Infographic [English] [Français]
 

Related Posts

  • a healthy vaccine market can increase uptake

    Building a stronger market: The benefits of investing in more TCVs

  • A photo showing a laboratory technician

    EuTCV trial begins in Senegal

  • Young men swimming in a lake created during the rainy season in Matam, Senegal. PATH/Gabe Bienczycki

    How Senegal can be a catalyst for new water and sanitation paradigms

Related Publications

  • Geographical distribution of risk factors for invasive non-typhoidal Salmonella at the subnational boundary level in sub-Saharan Africa

  • Validation and Identification of Invasive Salmonella Serotypes in Sub-Saharan Africa by Multiplex Polymerase Chain Reaction

  • Utilization of Healthcare in the Typhoid Fever Surveillance in Africa Program

cat
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Coalition against Typhoid
2175 K Street, NW, Suite 400
Washington, DC 20037
© 2018. Coalition Against Typhoid. All Rights Reserved.
  • Contact Us
  • Privacy Policy
  • Facebook
  • Twitter
Top